Expansion for Lloyds Chemists
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.LLOYDS Chemists, the high- growth pharmaceuticals wholesaler and retailer, is planning further regional expansion of its chemist and health goods store chains with another 100 retail outlets expected to open this year.
The announcement accompanied results that saw profits in the year to 30 June increase 17 per cent to pounds 58.3m.
Turnover increased 17 per cent to pounds 939.7m. The company emphasised the success of the veterinary division, which saw a 33 per cent increase in turnover to pounds 60m and a 75 per cent increase in pre-tax profits to pounds 3.5m.
The board proposes to increase the final dividend to 6.8p, taking the total to 9.5p, an increase of 31 per cent. The total dividend is covered three and half times by attributable profit.
Less impressive was the growth in the pharmaceutical division. Turnover growth of 33 per cent was accompanied by margins falling from 8.7 per cent to 8.1 per cent.
Peter Lloyd, chairman, denied margins were being squeezed by increased competition, and said this reflected the change in emphasis from high-margin, low- turnover ethical goods to low-margin, high-turnover health goods.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments